Cat.#: ACPP-1074
| Despition | Myocilin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1757 | Human Artemin Protein (AC1757) | 5 µg | inquiry |
| ACPP-1552 | Human CDNF Protein (AC1552) | 5 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
| ACPP-1414 | Human BEX1 Protein (AC1414) | 2 µg | inquiry |
| ACPP-1535 | Human VAMP8 Protein (AC1535) | 5 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1138 | Recombinant Human Semaphorin 7a Protein (6×His Tag) (AC1138) | 50 µg | inquiry |
| ACPP-1261 | TSH beta Blocking Peptide (AC1261) | 250 µg | inquiry |
| ACPP-1234 | SOX10 Blocking Peptide (AC1234) | 250 µg | inquiry |
| ACPP-1637 | Human NRN1 Protein, His (AC1637) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.